BMY vs IAC · P/E 17, rev $24.46B vs P/E 26, rev $3.81B
Bristol-Myers Squibb Company (BMY) versus IAC Inc. (IAC) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
IAC Inc. (IAC) is a internet content & information company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported IAC revenue for 2024-12-31 was $3.81B. Net income was -$533.3M. Revenue was down 12.8% from 2023-12-31 to 2024-12-31. IAC currently screens at market cap $3.14B and trailing P/E 25.9.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. IAC currently screens at market cap $3.14B and trailing P/E 25.9.
Not investment advice. Open the BMY and IAC stock pages for the full models.
Not investment advice.